rs2228083

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000031.6(ALAD):​c.414C>T​(p.Asn138Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.08 in 1,613,900 control chromosomes in the GnomAD database, including 5,497 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.081 ( 559 hom., cov: 33)
Exomes 𝑓: 0.080 ( 4938 hom. )

Consequence

ALAD
NM_000031.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.590

Publications

16 publications found
Variant links:
Genes affected
ALAD (HGNC:395): (aminolevulinate dehydratase) The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway; zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
ALAD Gene-Disease associations (from GenCC):
  • porphyria due to ALA dehydratase deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 9-113390660-G-A is Benign according to our data. Variant chr9-113390660-G-A is described in ClinVar as Benign. ClinVar VariationId is 364650.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.59 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0868 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALADNM_000031.6 linkc.414C>T p.Asn138Asn synonymous_variant Exon 6 of 12 ENST00000409155.8 NP_000022.3 P13716-1A0A140VJL9Q6ZMU0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALADENST00000409155.8 linkc.414C>T p.Asn138Asn synonymous_variant Exon 6 of 12 1 NM_000031.6 ENSP00000386284.3 P13716-1

Frequencies

GnomAD3 genomes
AF:
0.0812
AC:
12358
AN:
152186
Hom.:
558
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0872
Gnomad AMI
AF:
0.0727
Gnomad AMR
AF:
0.0609
Gnomad ASJ
AF:
0.0343
Gnomad EAS
AF:
0.0931
Gnomad SAS
AF:
0.0682
Gnomad FIN
AF:
0.0879
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0838
Gnomad OTH
AF:
0.0822
GnomAD2 exomes
AF:
0.0746
AC:
18643
AN:
249910
AF XY:
0.0747
show subpopulations
Gnomad AFR exome
AF:
0.0862
Gnomad AMR exome
AF:
0.0397
Gnomad ASJ exome
AF:
0.0319
Gnomad EAS exome
AF:
0.0935
Gnomad FIN exome
AF:
0.0916
Gnomad NFE exome
AF:
0.0823
Gnomad OTH exome
AF:
0.0792
GnomAD4 exome
AF:
0.0798
AC:
116664
AN:
1461596
Hom.:
4938
Cov.:
34
AF XY:
0.0795
AC XY:
57789
AN XY:
727084
show subpopulations
African (AFR)
AF:
0.0850
AC:
2846
AN:
33474
American (AMR)
AF:
0.0426
AC:
1905
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.0315
AC:
824
AN:
26126
East Asian (EAS)
AF:
0.0652
AC:
2589
AN:
39686
South Asian (SAS)
AF:
0.0691
AC:
5956
AN:
86242
European-Finnish (FIN)
AF:
0.0902
AC:
4815
AN:
53370
Middle Eastern (MID)
AF:
0.0376
AC:
217
AN:
5768
European-Non Finnish (NFE)
AF:
0.0835
AC:
92802
AN:
1111864
Other (OTH)
AF:
0.0780
AC:
4710
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
6905
13809
20714
27618
34523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3354
6708
10062
13416
16770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0812
AC:
12372
AN:
152304
Hom.:
559
Cov.:
33
AF XY:
0.0801
AC XY:
5965
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0872
AC:
3627
AN:
41576
American (AMR)
AF:
0.0608
AC:
930
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0343
AC:
119
AN:
3472
East Asian (EAS)
AF:
0.0937
AC:
484
AN:
5164
South Asian (SAS)
AF:
0.0683
AC:
330
AN:
4832
European-Finnish (FIN)
AF:
0.0879
AC:
933
AN:
10612
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0838
AC:
5699
AN:
68024
Other (OTH)
AF:
0.0823
AC:
174
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
584
1169
1753
2338
2922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0793
Hom.:
789
Bravo
AF:
0.0775
Asia WGS
AF:
0.0660
AC:
230
AN:
3478
EpiCase
AF:
0.0761
EpiControl
AF:
0.0695

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Porphobilinogen synthase deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
1.5
DANN
Benign
0.62
PhyloP100
-0.59
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228083; hg19: chr9-116152940; COSMIC: COSV107318289; COSMIC: COSV107318289; API